Boothbay Fund Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $768K | Buy |
+20,000
| New | +$768K | 0.01% | 603 |
|
|
2024
Q4 | – | Sell |
-11,567
| Closed | -$473K | – | 1469 |
|
|
2024
Q3 | $473K | Buy |
+11,567
| New | +$473K | 0.01% | 845 |
|
|
2024
Q2 | – | Sell |
-238,676
| Closed | -$10.2M | – | 1479 |
|
|
2024
Q1 | $10.2M | Buy |
238,676
+25,026
| +12% | +$1.07M | 0.2% | 55 |
|
|
2023
Q4 | $7.92M | Sell |
213,650
-490,672
| -70% | -$18.2M | 0.2% | 74 |
|
|
2023
Q3 | $25.5M | Sell |
704,322
-128,186
| -15% | -$4.65M | 0.61% | 8 |
|
|
2023
Q2 | $29.7M | Buy |
832,508
+23,736
| +3% | +$846K | 0.65% | 4 |
|
|
2023
Q1 | $28.8M | Buy |
808,772
+368,413
| +84% | +$13.1M | 0.59% | 5 |
|
|
2022
Q4 | $15.5M | Buy |
440,359
+221,930
| +102% | +$7.8M | 0.36% | 14 |
|
|
2022
Q3 | $6.43M | Buy |
+218,429
| New | +$6.43M | 0.16% | 92 |
|
|
2022
Q2 | – | Sell |
-94,850
| Closed | -$5.17M | – | 2103 |
|
|
2022
Q1 | $5.17M | Buy |
+94,850
| New | +$5.17M | 0.12% | 161 |
|
|
2021
Q4 | – | Sell |
-10,198
| Closed | -$487K | – | 1809 |
|
|
2021
Q3 | $487K | Buy |
+10,198
| New | +$487K | 0.01% | 905 |
|